• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核受体 PPARγ 可分别对血清素和脂肪酸代谢物作出反应。

The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.

机构信息

The Takara Bio Endowed Division, Department of Biomolecular Recognition, Institute for Protein Research, Osaka University, Open Laboratories of Advanced Bioscience and Biotechnology, Furuedai, Suita, Osaka, Japan.

出版信息

EMBO J. 2010 Oct 6;29(19):3395-407. doi: 10.1038/emboj.2010.197. Epub 2010 Aug 17.

DOI:10.1038/emboj.2010.197
PMID:20717101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2957204/
Abstract

The nuclear receptor, peroxisome proliferator-activated receptor γ (PPARγ), recognizes various synthetic and endogenous ligands by the ligand-binding domain. Fatty-acid metabolites reportedly activate PPARγ through conformational changes of the Ω loop. Here, we report that serotonin metabolites act as endogenous agonists for PPARγ to regulate macrophage function and adipogenesis by directly binding to helix H12. A cyclooxygenase inhibitor, indomethacin, is a mimetic agonist of these metabolites. Crystallographic analyses revealed that an indole acetate functions as a common moiety for the recognition by the sub-pocket near helix H12. Intriguingly, a serotonin metabolite and a fatty-acid metabolite each bind to distinct sub-pockets, and the PPARγ antagonist, T0070907, blocked the fatty-acid agonism, but not that of the serotonin metabolites. Mutational analyses on receptor-mediated transcription and coactivator binding revealed that each metabolite individually uses coregulator and/or heterodimer interfaces in a ligand-type-specific manner. Furthermore, the inhibition of the serotonin metabolism reduced the expression of the endogenous PPARγ-target gene. Collectively, these results suggest a novel agonism, in which PPARγ functions as a multiple sensor in response to distinct metabolites.

摘要

核受体过氧化物酶体增殖物激活受体 γ (PPARγ) 通过配体结合域识别各种合成和内源性配体。据报道,脂肪酸代谢物通过 Ω 环的构象变化激活 PPARγ。在这里,我们报告说,5-羟色胺代谢物通过直接结合螺旋 H12 作为内源性激动剂发挥作用,调节巨噬细胞功能和脂肪生成。环氧化酶抑制剂吲哚美辛是这些代谢物的模拟激动剂。晶体学分析表明,吲哚乙酸作为识别螺旋 H12 附近亚口袋的共同部分。有趣的是,5-羟色胺代谢物和脂肪酸代谢物各结合到不同的亚口袋,PPARγ 拮抗剂 T0070907 阻断了脂肪酸激动剂,但不阻断 5-羟色胺代谢物的激动剂。对受体介导的转录和共激活剂结合的突变分析表明,每种代谢物各自以配体类型特异性的方式使用共调节剂和/或异二聚体界面。此外,抑制 5-羟色胺代谢会降低内源性 PPARγ 靶基因的表达。总之,这些结果表明了一种新的激动作用,其中 PPARγ 作为一个多传感器,对不同的代谢物作出反应。

相似文献

1
The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.核受体 PPARγ 可分别对血清素和脂肪酸代谢物作出反应。
EMBO J. 2010 Oct 6;29(19):3395-407. doi: 10.1038/emboj.2010.197. Epub 2010 Aug 17.
2
Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.通过与内源性脂肪酸的共价修饰对过氧化物酶体增殖物激活受体γ(PPARγ)激活的结构洞察。
J Mol Biol. 2009 Jan 9;385(1):188-99. doi: 10.1016/j.jmb.2008.10.039. Epub 2008 Oct 19.
3
T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.T0070907是过氧化物酶体增殖物激活受体γ的选择性配体,具有生化和细胞活性拮抗剂的作用。
J Biol Chem. 2002 May 31;277(22):19649-57. doi: 10.1074/jbc.M200743200. Epub 2002 Mar 4.
4
Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.中链脂肪酸是选择性过氧化物酶体增殖物激活受体 (PPAR) γ 激活剂和全 PPAR 部分激动剂。
PLoS One. 2012;7(5):e36297. doi: 10.1371/journal.pone.0036297. Epub 2012 May 23.
5
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.合成配体和天然配体与核受体 PPARγ 的协同结合。
Elife. 2018 Dec 21;7:e43320. doi: 10.7554/eLife.43320.
6
Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.非甾体抗炎药对过氧化物酶体增殖物激活受体γ的调控机制
Nucl Recept Signal. 2015 Oct 5;13:e004. doi: 10.1621/nrs.13004. eCollection 2015.
7
2-Formyl-komarovicine promotes adiponectin production in human mesenchymal stem cells through PPARγ partial agonism.2-甲酰基 komarovicine 通过部分激动 PPARγ 促进人骨髓间充质干细胞分泌脂联素。
Bioorg Med Chem. 2018 Mar 1;26(5):1069-1075. doi: 10.1016/j.bmc.2018.01.019.
8
Structural basis for the activation of PPARgamma by oxidized fatty acids.氧化脂肪酸激活过氧化物酶体增殖物激活受体γ的结构基础。
Nat Struct Mol Biol. 2008 Sep;15(9):924-31. doi: 10.1038/nsmb.1474.
9
Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.对映异构体 PPARγ 激动剂活性差异的结构基础:S35 与备用结合位点的结合。
Biochim Biophys Acta Proteins Proteom. 2017 Jun;1865(6):674-681. doi: 10.1016/j.bbapap.2017.03.008. Epub 2017 Mar 22.
10
Peroxisome proliferator-activated receptor γ (PPARγ)-independent specific cytotoxicity against immature adipocytes induced by PPARγ antagonist T0070907.过氧化物酶体增殖物激活受体 γ(PPARγ)拮抗剂 T0070907 诱导的对未成熟脂肪细胞的 PPARγ 非依赖性特异性细胞毒性。
Biol Pharm Bull. 2013;36(9):1428-34. doi: 10.1248/bpb.b13-00024.

引用本文的文献

1
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.鉴定前列腺素还原酶2(PTGR2)抑制剂作为糖尿病和肥胖症的一种新治疗策略。
EMBO Mol Med. 2025 May;17(5):938-966. doi: 10.1038/s44321-025-00216-4. Epub 2025 Mar 21.
2
The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.过氧化物酶体增殖物激活受体在免疫介导的肠道疾病中的多功能作用。
Cells. 2024 Oct 12;13(20):1688. doi: 10.3390/cells13201688.
3
Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets.枝孢菌素和过氧化物酶体增殖物激活受体 γ:同一把枪,同样的子弹,更多的目标。
Biomolecules. 2024 Aug 13;14(8):998. doi: 10.3390/biom14080998.
4
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression.过氧化物酶体增殖物激活受体-γ 激动剂重新激活 ALDOC-NR2F1 轴,以增强对替莫唑胺的敏感性并抑制胶质母细胞瘤的进展。
Cell Commun Signal. 2024 May 13;22(1):266. doi: 10.1186/s12964-024-01645-3.
5
Molecular Markers of Early Immune Response in Tuberculosis: Prospects of Application in Predictive Medicine.结核分枝杆菌早期免疫反应的分子标志物:在预测医学中的应用前景。
Int J Mol Sci. 2023 Aug 26;24(17):13261. doi: 10.3390/ijms241713261.
6
The serotonin transporter sustains human brown adipose tissue thermogenesis.血清素转运体维持人类棕色脂肪组织的产热。
Nat Metab. 2023 Aug;5(8):1319-1336. doi: 10.1038/s42255-023-00839-2. Epub 2023 Aug 3.
7
Untargeted metabolomics on first trimester serum implicates metabolic perturbations associated with BMI in development of hypertensive disorders: a discovery study.孕早期血清的非靶向代谢组学研究表明,与体重指数相关的代谢紊乱与高血压疾病的发生有关:一项发现性研究。
Front Nutr. 2023 Jul 17;10:1144131. doi: 10.3389/fnut.2023.1144131. eCollection 2023.
8
Epigenomic regulation of macrophage polarization: Where do the nuclear receptors belong?核受体在巨噬细胞极化的表观遗传调控中的作用
Immunol Rev. 2023 Aug;317(1):152-165. doi: 10.1111/imr.13209. Epub 2023 Apr 19.
9
Relative profiling of L-tryptophan derivatives from selected edible mushrooms as psychoactive nutraceuticals to inhibit P-glycoprotein: a paradigm to contest blood-brain barrier.从选定的可食用蘑菇中提取的L-色氨酸衍生物作为抑制P-糖蛋白的精神活性营养保健品的相对分析:一种挑战血脑屏障的范例。
BioTechnologia (Pozn). 2021 Mar 31;102(1):55-64. doi: 10.5114/bta.2021.103762. eCollection 2021.
10
Valerenic Acid Promotes Adipocyte Differentiation, Adiponectin Production, and Glucose Uptake Its PPARγ Ligand Activity.缬草烯酸通过其过氧化物酶体增殖物激活受体γ(PPARγ)配体活性促进脂肪细胞分化、脂联素生成及葡萄糖摄取。
ACS Omega. 2022 Dec 13;7(51):48113-48120. doi: 10.1021/acsomega.2c06120. eCollection 2022 Dec 27.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.抑制肠道来源的血清素合成是骨质疏松症潜在的骨合成代谢治疗方法。
Nat Med. 2010 Mar;16(3):308-12. doi: 10.1038/nm.2098. Epub 2010 Feb 7.
3
Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain.脯氨酸顺/反异构酶 Pin1 通过直接结合激活功能-1 结构域调节过氧化物酶体增殖物激活受体 γ 的活性。
J Biol Chem. 2010 Jan 29;285(5):3126-32. doi: 10.1074/jbc.M109.055095. Epub 2009 Dec 7.
4
Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy.蛋白质分子在纳米级的大小和形状通过沉降、凝胶过滤和电子显微镜来确定。
Biol Proced Online. 2009 May 15;11:32-51. doi: 10.1007/s12575-009-9008-x.
5
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas.小型综述:核受体信号图谱NURSA的发展历程
Mol Endocrinol. 2009 Jun;23(6):740-6. doi: 10.1210/me.2009-0135. Epub 2009 May 7.
6
Structural basis for the activation of PPARgamma by oxidized fatty acids.氧化脂肪酸激活过氧化物酶体增殖物激活受体γ的结构基础。
Nat Struct Mol Biol. 2008 Sep;15(9):924-31. doi: 10.1038/nsmb.1474.
7
Structure of full-length PPARgamma-RXRalpha: a snapshot of a functional complex?全长PPARγ-RXRα的结构:一个功能性复合物的瞬间成像?
Cell Metab. 2009 Jan 7;9(1):8-10. doi: 10.1016/j.cmet.2008.12.010.
8
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.基于支架的吡格列酮(一种PPAR全激动型抗糖尿病药物)的发现。
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. doi: 10.1073/pnas.0811325106. Epub 2008 Dec 30.
9
Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.与15d - PGJ2复合的突变型PPARγ配体结合域的原子结构:共价结合配体对PPARγ/RXRα功能的新型调节机制
FEBS Lett. 2009 Jan 22;583(2):320-4. doi: 10.1016/j.febslet.2008.12.017. Epub 2008 Dec 26.
10
Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.过氧化物酶体增殖物激活受体γ(PPARγ)配体结合域与新型部分激动剂复合的晶体结构:疏水口袋的一个新区域可用于药物设计。
J Med Chem. 2008 Dec 25;51(24):7768-76. doi: 10.1021/jm800733h.